Imidazopyridine intermediates

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S127000, C544S333000

Reexamination Certificate

active

10555057

ABSTRACT:
The invention relates to compounds of the formula 1,in which the substituents and symbols have the meanings indicated in the description. The compounds are valuable intermediates for the preparation of pharmaceutical active compounds.

REFERENCES:
patent: 98/54188 (1998-12-01), None
patent: 01/72754 (2001-10-01), None
patent: 01/72755 (2001-10-01), None
patent: 01/72756 (2001-10-01), None
patent: 01/72757 (2001-10-01), None
patent: 02/34749 (2002-05-01), None
patent: 03/014120 (2003-02-01), None
patent: 03/014123 (2003-02-01), None
patent: 03/016310 (2003-02-01), None
Abe et al., J. med. Chem., “A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework”, 1998, vol. 41, pp. 564-578.
“Information Update: vol. 1-25, No. 6”,Drugs of the Future 2001, vol. 26, No. 6, pp. 577-625, (2001).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Imidazopyridine intermediates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazopyridine intermediates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridine intermediates will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3826991

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.